Citi analyst Joanne Wuensch has reiterated their bullish stance on ISRG stock, giving a Buy rating today.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Joanne Wuensch’s rating is based on Intuitive Surgical’s strong financial performance and strategic advancements. The company reported a significant revenue increase of 23% year-over-year, surpassing market expectations, with notable growth in its Instruments and Accessories and Systems segments. Additionally, the global interest in the da Vinci System, particularly the DV5 model, has been rising, with new placements in Japan and Europe contributing to the company’s expansion.
Furthermore, the procedural growth in various surgical categories, such as general surgery and colorectal procedures, highlights the increased utilization of Intuitive Surgical’s systems. The company’s management has also raised its guidance for future procedural growth and improved its margin forecasts, indicating confidence in sustained performance. These factors, along with the strategic regulatory advancements in new surgical applications, underpin Joanne Wuensch’s Buy rating for Intuitive Surgical.
ISRG’s price has also changed slightly for the past six months – from $468.320 to $462.740, which is a -1.19% drop .